PRO46 EMICIZUMAB PROPHYLAXIS IS A COST-SAVING OPTION FOR HEMOPHILIA A PATIENTS WITH INHIBITORS IN KOREA: A COST-EFFECTIVENESS ANALYSIS
Abstract
Authors
H. Lee H. Cho J.W. Han A. Kim S. Park M. Lee S. Cho D. Baik H.Y. Kang
H. Lee H. Cho J.W. Han A. Kim S. Park M. Lee S. Cho D. Baik H.Y. Kang
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now